Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Más filtros











Base de datos
Intervalo de año de publicación
1.
Int Urogynecol J ; 27(5): 697-708, 2016 May.
Artículo en Inglés | MEDLINE | ID: mdl-26272202

RESUMEN

INTRODUCTION AND HYPOTHESIS: Bladder pain syndrome/interstitial cystitis (BPS/IC) has various treatments; however, no standardized treatment has been established. The aim was to analyze different types of treatment of BPS/IC and their effectiveness. METHODS: A literature review with a search strategy for articles related to BPS/IC published between 1990 and 2014 was conducted on MEDLINE, PUBMED, and SCOPUS. Only randomized controlled trials in women were included in the meta-analysis, while other experimental studies were used as bases for a systematic review of the topic. Clinical trial quality was defined according to the Jadad scale. RESULTS: Of 356 articles, 13 were included in the analysis. The intervention methods were as follows: instillation of hyaluronic acid, botulinum toxin A, intravesical lidocaine, hyperbaric chamber, massage, physiotherapy, phosphate-buffered saline, piroxicam in combination with doxepin, and others. We did not find any treatment with at least two randomized controlled trials for meta-analysis. Among the assessment tools for symptoms of BPS/IC, the most frequently used were the visual analogue scale, voiding record, and the O'Leary-Sant questionnaire. CONCLUSION: Existing studies were not able to define the best approach for the treatment of BPS/IC. The lack of standardized treatment may be related to the diversity of interventions used; therefore, further studies with better methodological quality are needed.


Asunto(s)
Adyuvantes Inmunológicos/administración & dosificación , Cistitis Intersticial/terapia , Ácido Hialurónico/administración & dosificación , Inhibidores de la Liberación de Acetilcolina/administración & dosificación , Administración Intravesical , Anestésicos Locales/administración & dosificación , Antiinflamatorios no Esteroideos/uso terapéutico , Antidepresivos/uso terapéutico , Toxinas Botulínicas Tipo A/administración & dosificación , Quimioterapia Combinada , Femenino , Humanos , Oxigenoterapia Hiperbárica , Lidocaína/administración & dosificación , Poliéster Pentosan Sulfúrico/administración & dosificación , Modalidades de Fisioterapia , Cloruro de Sodio/administración & dosificación
2.
J Eval Clin Pract ; 21(1): 21-7, 2015 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-25040704

RESUMEN

RATIONALE, AIMS AND OBJECTIVES: To analyse anthropometric parameters, clinical pain and experimental pain in women with chronic pelvic pain (CPP). METHODS: Ninety-one women with a clinical diagnosis of CPP, mean age of 40.03 ± 9.97 years, submitted to anthropometric evaluation based on body mass index (BMI) and percent body fat (%BF) using bioimpedance body composition monitor; pain intensity was determined by visual analogue scale (VAS), numerical categorical scale (NCS) and McGill Pain Questionnaire; experimental pain was determined by transcutaneous electrical nerve stimulation (TENS), and anxiety and depression symptoms were determined by the Hospital Anxiety and Depression scale. RESULTS: A total of 54.8% of the women showed %BF >32 risk of disease associated with obesity. Regarding the anthropometric data, a statistically significant difference was observed between groups for both BMI and %BF (P<0.0001). In the analysis of pain intensity by the VAS, NCS and total McGill, there was no significant difference between the groups, and experimental pain by TENS revealed significant difference only between the normal weight and overweight groups (P=0.0154). The results of anxiety symptoms were above the cut-off point in all groups, with no significant difference between them (P=0.3710). The depression symptoms were below the cut-off point in the normal weight group and above the cut-off point in the overweight and obese groups, 9.469(4.501) and 9.741(4.848), respectively, with no significant difference between them (P=0.6476). CONCLUSION: Evaluation of anthropometric parameters and pain measurements can be applied in clinical practice, making a contribution to the diagnosis and influencing the choice of a more effective treatment for women with CPP.


Asunto(s)
Índice de Masa Corporal , Sobrepeso/complicaciones , Dolor Pélvico/complicaciones , Adulto , Ansiedad/complicaciones , Pesos y Medidas Corporales , Enfermedad Crónica , Depresión/complicaciones , Femenino , Humanos , Persona de Mediana Edad , Dimensión del Dolor , Estimulación Eléctrica Transcutánea del Nervio
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA